Ad
related to: SARS-CoV-2Human/Mouse/Rat/Humanized/Chimeric Recombinant Antibodies for Research Use. Free Inquiry! Applicable for WB, Cyt, CyTOF, ELISA, FC, FuncS, ICC, IHC, Inhib, IP, Neut, RIA, et al.
- Therapeutic Antibodies
Recombinant antibodies for
clinical trials.
- Advanced Antibodies
Everything you need to know about
engineered antibodies.
- Therapeutic Antibodies
Search results
SARS‑CoV‑2 is a strain of the species severe-acute-respiratory-syndrome-related coronavirus (SARSr-CoV), as is SARS-CoV-1, the virus that caused the 2002–2004 SARS outbreak. There are animal
Oct 6, 2020 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute...
- Ben Hu, Hua Guo, Peng Zhou, Zheng Li Shi
- 2021
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention.
Dec 12, 2021 · Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), also known as “the novel coronavirus” due to genome variation relative to previously identified coronaviruses, is a positive sense RNA virus and the etiological agent of COVID-19.
- Jahangir Emrani, Maryam Ahmed, Liesl Jeffers-Francis, John C. Teleha, Nathan Mowa, Robert H. Newman,...
- 10.1016/j.ijbiomac.2021.10.172
- 2021
- 2021/12/12
Nov 20, 2023 · What are variants of SARS-COV-2, the virus that causes COVID-19? It is usual for viruses to change and evolve as they spread between people over time. When these changes become significantly different to a previously detected virus, these new virus types are known as “variants.”
- It is usual for viruses to change and evolve as they spread between people over time. When these changes become significantly different to a previo...
- A Variant Under Monitoring (VUM) is a term used to signal to public health authorities that a SARS-CoV-2 variant may require prioritized attention...
- To protect yourself and others from all SARS-CoV-2 (COVID-19), including all the virus variants, consider the following: wear a mask when in crowde...
- As with all viruses, SARS-CoV-2, the virus that causes COVID-19, will continue to evolve as long as it continues to spread. The more that the virus...
- The COVID-19 vaccines with WHO Emergency Use Listing (EUL) or approval from stringent regulatory authorities (SRAs) provide different levels of pro...
Mar 27, 2024 · It remains critical that global systems to detect signals of potential variants of interest (VOIs) or variants of concern (VOCs) and rapidly assess the risk posed by SARS-CoV-2 variants to public health are maintained, and data are shared, according to good principles and in a timely fashion.
Oct 23, 2020 · SARS-CoV-2 is genetically similar to SARS-CoV-1, but characteristics of SARS-CoV-2—eg, structural differences in its surface proteins and viral load kinetics—may help explain its enhanced rate of transmission.
